Member Info for Timster

Also believe any announcement will be tied in with a Government announcement. A rapid test such as ours is pivotal to their testing strategy. They will hail it as their great success.....

uses the same affimers as in the Avacta ELISA test:
Using the same Affimer reagents that are incorporated into its rapid coronavirus saliva test being developed with Cytiva, Avacta has developed in-house a high performance ELISA laboratory test to detect the SARS-CoV-2 virus. Avacta will make the ELISA test available as a kit so that researchers globally can use it in their own laboratories to support research into the coronavirus.

which is 500 times more sensitive than the competition:
https://avacta.com/alastair-smith-gives-more-detail-on-the-sars-cov-2-elisa-laboratory-test/

IT WORKS!!! the issue is manufacturing capacity:
Avacta, in partnership with Cytiva, is developing a rapid test strip for use with patient saliva that aims to provide a result in a few minutes, indicating whether the patient is currently infected with the SARS-CoV-2 coronavirus. The test has the potential to be used for frequent mass testing of the population to promptly identify infectious individuals so that they can be isolated and treated, thereby reducing the spread of infection.

Abingdon Health provides innovative rapid testing solutions to a global client base and has Europe's largest lateral flow test contract manufacturing capacity. Abingdon Health's two sites in York and Doncaster, UK are able to produce millions of rapid tests per month.

Authorities around the world are now looking to carry-out frequent mass testing to identify the most infectious people promptly in order to reduce infection rates and combat the coronavirus pandemic. That requires a highly specific test to minimize false positives which would otherwise overwhelm healthcare systems. The Affimer reagents that we have generated are very specific to SARS-CoV-2 antigen and we are confident of meeting and exceeding the clinical performance requirements for identifying the most infectious people.



Manufacturing capacity is therefore the key challenge that has to be met in achieving widespread roll-out of Avacta's saliva-based rapid antigen test. We therefore continue to actively seek additional manufacturing partners globally to be able to provide the volume of tests that will be required in the UK and elsewhere. I look forward to updating the market on progress in that regard, and will keep the market informed on the key next steps of clinical validation and regulatory approval.

I for one am very very confident that Avacta will pull this off. Currently its out of their hands for clinical validation and manufacturing.

looks good, but from their website:

"Please note our tests are CE marked for professional use only, and is not for sale to the general public."

Nah just AVCT

But @hants that lovely 1 post person who came to save us all said the narrative had changed and it was all about vaccine. He was very convincing ..... ;)

160

He's done a deal with medusa19....... fallen for thier sales blurb ;)

I'll post again the quote from the manufacturing RNS that 100% confirms what you are saying. The challenge is ramping up manufacturing:

Authorities around the world are now looking to carry-out frequent mass testing to identify the most infectious people promptly in order to reduce infection rates and combat the coronavirus pandemic. That requires a highly specific test to minimize false positives which would otherwise overwhelm healthcare systems. The Affimer reagents that we have generated are very specific to SARS-CoV-2 antigen and we are confident of meeting and exceeding the clinical performance requirements for identifying the most infectious people.

Manufacturing capacity is therefore the key challenge that has to be met in achieving widespread roll-out of Avacta's saliva-based rapid antigen test. We therefore continue to actively seek additional manufacturing partners globally to be able to provide the volume of tests that will be required in the UK and elsewhere. I look forward to updating the market on progress in that regard, and will keep the market informed on the key next steps of clinical validation and regulatory approval.

they are being slightly economical with the truth about their test

Don't forget the US market AND the rest of the world!!

Very poor deramping mortgage! Have you emailed sir Al yet? He'd probably want to know you're an investor though.

BAMS can help with government test and trace capacity.
LFT is the holy grail!!!

We've also been told as much in the last manufacturing partner RNS. Nothing has changed this statement still stands:

Authorities around the world are now looking to carry-out frequent mass testing to identify the most infectious people promptly in order to reduce infection rates and combat the coronavirus pandemic. That requires a highly specific test to minimize false positives which would otherwise overwhelm healthcare systems. The Affimer reagents that we have generated are very specific to SARS-CoV-2 antigen and we are confident of meeting and exceeding the clinical performance requirements for identifying the most infectious people.



Manufacturing capacity is therefore the key challenge that has to be met in achieving widespread roll-out of Avacta's saliva-based rapid antigen test. We therefore continue to actively seek additional manufacturing partners globally to be able to provide the volume of tests that will be required in the UK and elsewhere. I look forward to updating the market on progress in that regard, and will keep the market informed on the key next steps of clinical validation and regulatory approval."

One day closer to validation

@mortgagefreeman why do you get so excited about a Myles tweet and hang off his every word. But constantly moan about how long it's taken to condense a 2 year process into your perceived timelines?

so they are still testing! shame I sold all my shares now because that new poster said it was all over :(

if he doesn't mention testing, that's confirmation that is all over :)

@Nixynoo dont worry children cant catch it! and as long as you leave a pub before 10pm there is also no chance of it getting you

I'll have them...

More counties in Wales in lockdown

Do people really think we are going to sit this out until a POSSIBLE vaccine middle of next year and abandon mass testing with a "pregnancy style" lateral flow device?